Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomide
Sign Up to like & getrecommendations! Published in 2019 at "Endocrine"
DOI: 10.1007/s12020-019-01996-9
Abstract: To evaluate the impact of temozolomide (TMZ) introduction on the survival of patients with pituitary carcinoma (PC) compared to aggressive pituitary adenoma (APA). Retrospective analysis of the Surveillance Epidemiology and End-Results database (SEER), including patients… read more here.
Keywords: introduction; harboring pituitary; cause mortality; patients harboring ... See more keywords